tirzepatide shot stings Tirzepatide-Induced Injection Site Reaction Importance of Rotating Injection Sites

GLP-1 GLP-1 GLP1 GLP-1 GLP-1 3GLP-1 11 11GLP-1 11 11GLP-12 1 1GLP-11 GLP-1 GLP-124 GLP-124 GLP-1 GLP-1 GLP-1

The FDA has approved semaglutide for management of type 2 diabetes and weight management for adults with a BMI over 30

Glucagon-like peptide-1 ( GLP-1 ) receptor agonists, such as semaglutide (Wegovy) or tirzepatide (Zepbound), reduce hunger and cravings, making it easier to maintain a calorie deficit during plateaus

Working With Your Healthcare Provider Nausea is common, but you do not have to suffer through it without support

From the phase 3 trials at the 9 mg and 12 mg doses: Nausea: 38.1% (9 mg) to 43.2% (12 mg) versus 10.7% with placebo Diarrhea: 34.7% (9 mg) to 33.1% (12 mg) versus 13.4% with placebo Constipation: 21.8% (9 mg) to 25.0% (12 mg) versus 8.7% with placebo Vomiting: 20.4% (9 mg) to 20.9% (12 mg) Compare those numbers to Mounjaro and the difference is clear

Read More What Are GLP-1 Patches